IF YOU’RE 45 OR OLDER, WE’VE GOT GOOD NEWS FOR YOU.
AND BAD NEWS FOR CANCER.
Thanks to advances in both diagnostic science and statistical analysis, the good news is that adults 45 and over are now eligible for the most effective life-saving colon cancer prevention method yet devised:
The GIGenius™ enhanced colonoscopy at US Digestive Health.
Not all colonoscopies are created equal.
USDH has recently made the region’s first and nation’s largest installation of GIGenius intelligent endoscopy modules, a revolutionary computer-aided detection system powered by Artificial Intelligence. In clinical studies, GIGenius enhanced colonoscopy has demonstrated a 50% reduction in missed colorectal polyps versus standard colonoscopy alone. Consequently, by using both methods, USDH Physicians are able to diagnose colorectal cancer with unsurpassed accuracy.
It couldn’t hurt. And it sure could help.
Contrary to what you may believe, a colonoscopy is fast, painless, and fully covered by most insurance for adults 45 and over. It’s also by far the most effective way to diagnose the #2 most lethal cancer1. And the sooner we find it, the better we can stop it2.
Find out for yourself. And for those you love.
If caught early, colorectal cancer can be treated successfully with survival rates of 90%. And with more than 150 GI specialists in 26 locations and 14 endoscopy centers, USDH physicians have conducted more colonoscopies, treated more cancer, and saved more lives than any gastroenterology practice in our region.
No appointment is necessary at any of our Endoscopy Center locations.
1 Cancer.Net. Colorectal Cancer: Statistics. January 2020. Available at: https://www.cancer.net/cancer-types/colorectal-cancer/statistics. Accessed January 22, 2021
2 In a cohort study of more than 100,000 American women, , compared with no endoscopy, initiation of endoscopy before 50 years of age was associated with a reduced risk of Colorectal Cancer, including CRC diagnosed before 55 years of age. Screening before 50 years of age was associated with greater absolute reduction in CRC risk compared with initiation of CRC screening at 50 years of age or later. https://jamanetwork.com/journals/jamaoncology/article-abstract/2792009
